Patient Centered Experiences in Breast Cancer
- 1 May 2007
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Medical Care
- Vol. 45 (5), 431-439
- https://doi.org/10.1097/01.mlr.0000257193.10760.7f
Abstract
Background: Among breast cancer patients, tamoxifen use is associated with reduced risk of disease relapse and death, but it is often difficult for women to sustain therapy during the 5 years required to obtain maximum benefit. Objectives: We sought to examine the influence of patient-centered care activities on ongoing tamoxifen use 4 years after initiation, we examined key components of patient-centered care and rates of ongoing tamoxifen. Methods: Using a prospective cohort study that included observational data from the National Initiative for Cancer Care Quality (NICCQ), we studied 881 patients with stage I-III breast cancer who were registered with an initial diagnosis in 1998 by an American College of Surgeons-approved hospital cancer registry in 1 of 5 metropolitan areas, who initiated tamoxifen treatment. A patient survey and medical record abstraction were used as measurements. Results: Among women who initiated tamoxifen, 79% were still taking it 4 years later. Other than older age and the severity of side effects, other demographic, clinical and cancer characteristics, and treatments did not predict ongoing tamoxifen use. In contrast, after adjusting for these factors, the proportion of patients with ongoing tamoxifen use was lower for patients reporting less support than needed (82% vs. 69%, P = 0.0051), less than wanted role in decision-making (80% vs. 70%, P = 0.0486), decision-making about tamoxifen without doctor input (79% vs. 64%, P = 0.0182), and for patients who weren't told about side effects in advance (82% vs. 72%, P = 0.0016). Conclusions: Although age and the severity of side-effects remain important, patient-centered care was a primary mediator of patient adherence to ongoing cancer treatment with tamoxifen.Keywords
This publication has 34 references indexed in Scilit:
- Results of the National Initiative for Cancer Care Quality: How Can We Improve the Quality of Cancer Care in the United States?Journal of Clinical Oncology, 2006
- Patient Beliefs and Tamoxifen Discontinuance in Older Women With Estrogen Receptor—Positive Breast CancerJournal of Clinical Oncology, 2004
- Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancerCancer, 2003
- Randomized Trial of 2 Versus 5 Years of Adjuvant Tamoxifen for Women Aged 50 Years or Older With Early Breast Cancer: Italian Interdisciplinary Group for Cancer Evaluation Study of Adjuvant Treatment in Breast Cancer 01Journal of Clinical Oncology, 2003
- Consultation for asthma: results of a generalist surveyAnnals of Allergy, Asthma & Immunology, 1999
- Effectiveness of Interventions to Improve Patient ComplianceMedical Care, 1998
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trialThe Lancet, 1998
- Recall bias in epidemiologic studiesJournal of Clinical Epidemiology, 1990
- Assessing the Effects of Physician-Patient Interactions on the Outcomes of Chronic DiseaseMedical Care, 1989
- The effects of physician communications skills on patient satisfaction; Recall, and adherenceJournal of Chronic Diseases, 1984